Ranked by engagement
Top topics — all time page 20
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 20 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Taste changes and food aversion, reported and discussed
Posting this under the heading it deserves: Taste changes and food aversion, reported and discussed Everything below is what sits behind that. I have read the maintained page on this and I still have a gap,…
|
+40 | 47 | 28k | 20mo |
|
Coming back to: A community side-effect dataset, with its response rate and biases
On the subject in the title: A community side-effect dataset, with its response rate and biases Working notes rather than a conclusion. Posting the method first, because I know what the first three replies…
|
+27 | 31 | 46k | 9mo |
|
A checklist for reading a certificate in under two minutes — does this still hold?
A checklist for reading a certificate in under two minutes — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to understand what this…
|
+49 | 55 | 15k | 9mo |
|
[2026 update] People with a low starting BMI: where the evidence stops
People with a low starting BMI: where the evidence stops Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
+19 | 23 | 62k | 23mo |
|
Criticising the method without criticising the authors — one year on
On the subject in the title: Criticising the method without criticising the authors — one year on Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before posting;…
|
+16 | 20 | 61k | 11mo |
|
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction
The question in the title: Why a glucagon receptor agonist in a weight-loss compound is not a contradiction I will give what I have already checked below so nobody repeats it. Comparing LEADER ( N Engl J Med…
|
+43 | 47 | 19k | 2d |
|
Revisiting: Primary endpoint hierarchies and why order matters
Posting this under the heading it deserves: Revisiting: Primary endpoint hierarchies and why order matters Everything below is what sits behind that. Comparing SURMOUNT-4 ( JAMA , 2024) with SURPASS-2 ( N…
|
+21 | 25 | 46k | 3mo |
|
Packaging that arrived damaged: documenting it properly
Packaging that arrived damaged: documenting it properly Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than…
|
+43 | 49 | 26k | 1d |
|
Review: a draft on reconstitution arithmetic, with objections — one year on
Review: a draft on reconstitution arithmetic, with objections — one year on Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the…
|
+46 | 51 | 11k | 20h |
|
Revisiting: Journal club: SURMOUNT-1, read without the press release
On the subject in the title: Revisiting: Journal club: SURMOUNT-1, read without the press release Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it before…
|
+54 | 62 | 1.5k | 26d |
|
[2026 update] Currency conversion and the cost you did not see
Posting this under the heading it deserves: Currency conversion and the cost you did not see Everything below is what sits behind that. A logistics question, since the answers here are usually better than…
|
+21 | 26 | 52k | 2d |
|
EU-wide position versus national implementation — what changed since
EU-wide position versus national implementation — what changed since Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included,…
|
+22 | 26 | 58k | 2mo |
|
Shakes versus food: a pragmatic assessment
Shakes versus food: a pragmatic assessment Writing it up because I had to work it out twice and would rather nobody else did. Maintenance rather than loss, which is the part of this that almost nobody writes…
|
+22 | 26 | 53k | 20h |
|
Levothyroxine timing: a real interaction with a simple fix
Levothyroxine timing: a real interaction with a simple fix Writing it up because I had to work it out twice and would rather nobody else did. Reporting something rather than asking about it, in case the…
|
+20 | 24 | 60k | 18mo |
|
Revisiting: List price versus negotiated price versus what you pay
Revisiting: List price versus negotiated price versus what you pay — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is…
|
+24 | 28 | 50k | 12mo |
|
Oxidation pathways for methionine and tryptophan
Posting this under the heading it deserves: Oxidation pathways for methionine and tryptophan Everything below is what sits behind that. Working through the identity arithmetic and I would like it checked.…
|
+58 | 63 | 1k | 19mo |
|
Aggregates and why a purity assay may miss them entirely
Aggregates and why a purity assay may miss them entirely Writing it up because I had to work it out twice and would rather nobody else did. A documentation question rather than an analytical one. I have a…
|
+61 | 69 | 2.9k | 6mo |
|
Certificates issued by the seller versus by a laboratory
Posting this under the heading it deserves: Certificates issued by the seller versus by a laboratory Everything below is what sits behind that. I would like to understand what this number means before I…
|
+58 | 65 | 1.2k | 15mo |
|
NHS criteria and how they are applied in practice
NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines…
|
+37 | 42 | 31k | 2d |
|
The C-cell question: rodent findings and their human context — what changed since
The C-cell question: rodent findings and their human context — what changed since — setting out what I have, and where I think it stops being reliable. I have seen FLOW ( N Engl J Med , 2024) cited in support…
|
+61 | 65 | 1.3k | 22mo |
|
[2026 update] Area percent versus weight percent: the confusion that causes most arguments
On the subject in the title: Area percent versus weight percent: the confusion that causes most arguments Working notes rather than a conclusion. Posting the method first, because I know what the first three…
|
+65 | 70 | 1.1k | 16d |
|
What changed in 2026, by region — does this still hold?
What changed in 2026, by region — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated, because everything in…
|
+20 | 25 | 50k | 1d |
|
An emergency department visit, described afterwards
An emergency department visit, described afterwards Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
+56 | 62 | 1.4k | 11mo |
|
Second pass at: Pharmacy supply in the UK and the questions you will be asked
Second pass at: Pharmacy supply in the UK and the questions you will be asked Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail…
|
+46 | 53 | 14k | 12mo |
|
A structured critique template this community uses — a second dataset
On the subject in the title: A structured critique template this community uses — a second dataset Working notes rather than a conclusion. Session topic: SELECT ( N Engl J Med , 2023). Please read it before…
|
+47 | 51 | 16k | 15h |
|
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this…
|
+16 | 20 | 56k | 12mo |
|
Second pass at: Robustness: the parameters worth deliberately varying
On the subject in the title: Second pass at: Robustness: the parameters worth deliberately varying Working notes rather than a conclusion. I would like to understand what this number means before I repeat it…
|
+61 | 66 | 9.5k | 3mo |
|
Follow-up: A parcel that arrived warm: a decision process, not a verdict
Posting this under the heading it deserves: A parcel that arrived warm: a decision process, not a verdict Everything below is what sits behind that. A question about technique rather than about dose. I have…
|
+49 | 59 | 1.2k | 2mo |
|
Revisiting: Review: an evidence digest and the citation check that delayed it
Revisiting: Review: an evidence digest and the citation check that delayed it — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation…
|
+54 | 58 | 8.2k | 5mo |
|
Ultrasound and skinfolds: operator dependence in practice
Ultrasound and skinfolds: operator dependence in practice — setting out what I have, and where I think it stops being reliable. Maintenance rather than loss, which is the part of this that almost nobody…
|
+72 | 76 | 2.7k | 2d |